Barclays Forecasts Strong Price Appreciation for Bath & Body Works (NYSE:BBWI) Stock

Key Points

• Barclays has increased its price target for Bath & Body Works (NYSE:BBWI) from $30.00 to $32.00, suggesting an 8.60% potential upside from the current price.
• JPMorgan Chase raised its price target from $40.00 to $46.00, while Goldman Sachs adjusted theirs from $44.00 to $43.00, indicating strong analyst interest in the stock.
• Bath & Body Works announced a quarterly EPS of $0.37, aligning with market estimates, as the company projects FY 2025 EPS between $3.350-3.600.

Bath & Body Works (NYSE:BBWI - Free Report) had its price target upped by Barclays from $30.00 to $32.00 in a research report report published on Friday, MarketBeat reports. Barclays currently has an equal weight rating on the stock.

BBWI has been the subject of a number of other research reports. Wall Street Zen downgraded shares of Bath & Body Works from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Wells Fargo & Company boosted their price target on shares of Bath & Body Works from $40.00 to $44.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 14th. Piper Sandler set a $39.00 target price on shares of Bath & Body Works and gave the company an "overweight" rating in a research report on Thursday, May 15th. Citigroup cut their price target on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating on the stock in a report on Tuesday, August 19th. Finally, Telsey Advisory Group restated an "outperform" rating and issued a $38.00 target price on shares of Bath & Body Works in a research note on Thursday, August 28th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $41.62.

Bath & Body Works Price Performance

BBWI traded up $0.99 on Friday, hitting $30.55. The company had a trading volume of 3,462,012 shares, compared to its average volume of 5,202,589. Bath & Body Works has a 52-week low of $24.94 and a 52-week high of $41.87. The stock has a fifty day simple moving average of $30.66 and a 200-day simple moving average of $30.68. The firm has a market capitalization of $6.30 billion, a P/E ratio of 9.08, a P/E/G ratio of 0.98 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, hitting analysts' consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The company had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same period in the previous year, the business earned $0.37 EPS. The firm's revenue for the quarter was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Equities research analysts expect that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 5th. Stockholders of record on Friday, August 22nd will be paid a $0.20 dividend. The ex-dividend date is Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.6%. Bath & Body Works's dividend payout ratio is presently 23.74%.

Institutional Trading of Bath & Body Works

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. T. Rowe Price Investment Management Inc. increased its stake in shares of Bath & Body Works by 7.6% in the first quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company's stock worth $334,029,000 after acquiring an additional 781,681 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Bath & Body Works by 11.5% in the second quarter. JPMorgan Chase & Co. now owns 7,080,106 shares of the company's stock worth $212,120,000 after acquiring an additional 733,000 shares during the period. Victory Capital Management Inc. increased its stake in shares of Bath & Body Works by 14,732.0% in the first quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock worth $206,119,000 after acquiring an additional 6,752,274 shares during the period. Alliancebernstein L.P. increased its stake in shares of Bath & Body Works by 5.8% in the second quarter. Alliancebernstein L.P. now owns 5,737,796 shares of the company's stock worth $171,904,000 after acquiring an additional 315,738 shares during the period. Finally, Cooper Creek Partners Management LLC increased its stake in shares of Bath & Body Works by 42.7% in the second quarter. Cooper Creek Partners Management LLC now owns 5,409,919 shares of the company's stock worth $162,081,000 after acquiring an additional 1,619,276 shares during the period. Institutional investors and hedge funds own 95.14% of the company's stock.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.